Results 141 to 150 of about 6,372 (199)

How Should We Treat Severe Malaria in the Setting of Artemisinin Partial Resistance? [PDF]

Am J Trop Med Hyg
Rosenthal PJ, Kamya MR, Namazzi R, John CC.   +3 more
europepmc   +1 more source

Efficacies of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open-label, phase 4 clinical trial. [PDF]

Lancet Infect Dis
Kamya MR, Nankabirwa JI, Ebong C, Asua V, Kiggundu M, Orena S, Okitwi M, Tukwasibwe S, Agaba B, Kyabayinze D, Opigo J, Rutazana D, Binagwa B, Mugwanya E, Babirye S, Sebikaari G, Condo PM, Appiah G, Nsobya SL, Conrad MD, Rosenthal PJ, Moriarty LF, Yeka A.   +22 more
europepmc   +1 more source

Spatio-temporal trends of artemisinin-based combination therapy efficacy from 2010 to 2024 in sub-Saharan Africa: a systematic review and meta-analysis. [PDF]

BMC Infect Dis
Bohissou FET, Nassa GJW, Sondo P, Rouamba T, Inoue J, Kaboré B, Asua V, Held J, Tinto H.   +8 more
europepmc   +1 more source

A dynamic pharmacometric framework defining the relationship between ivermectin exposure and mosquito lethality

Hoglund RM, Kobylinski KC, Jittamala P, Hanboonkunupakarn B, Wamaket N, Sriwichai P, Phasomkusolsil S, White NJ, Day NP, Tarning J.   +9 more
europepmc   +1 more source

Discovery of the small molecular inhibitors against TRPV6 as potential anti-cancer agents by structural based virtual screening. [PDF]

Front Chem
Wang L, Deng X, Hu R, Tan S, Zhang L, Rong M, Hu L, Feng X, Zou H, Wu J.   +9 more
europepmc   +1 more source

<i>In Silico</i> Pharmacokinetic Profile and Antimalarial Efficacy of 3-Chloro-4-(4-Chlorophenoxy)Aniline. [PDF]

Biochem Res Int
Waithera MW, Kimani SK, Njoroge S, Nyahanga T, Kinyua JK.   +4 more
europepmc   +1 more source

Field observations on the antimalarial piperaquine.

Chinese medical journal, 1982
L, Chen, F Y, Qu, Y C, Zhou
openaire   +1 more source

Parasite clearance of two commonly administered artemisinin-based combination therapies in under-five children with uncomplicated malaria in a comprehensive healthcare facility in South-Western Nigeria: a randomised controlled trial. [PDF]

BMC Infect Dis
Ahmed AA, Bello IS, Adewole TO, Olowookere SA, Oyegbade OO, Ogundokun AO, Olajubu TO, Funwei RI, Ojurongbe O, Adepoju DA, Bello AB, Adegboyega AA, Anjorin AO, Anjorin AO, Akinola OO, Adewumi KM, Omenugha MK, Salami OT, Familusi AO, Akande EO.   +19 more
europepmc   +1 more source